| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2007;116:1942-1951.)
© 2007 American Heart Association, Inc.
Preventive Cardiology |
From INSERM U780-IFR69 (B.B.), Villejuif, France; Faculty of Medicine (B.B.), Université Paris-Sud, Orsay, France; Cardiothoracic Unit (J.E.D.), Great Ormond Street Hospital for Children, London, United Kingdom; Cardiac Unit, Institute of Child Health and Grown Up Congenital Heart Disease (J.E.D.), University College, London, UK; Laval Hospital Research Center (J.-P.D.), Sainte-Foy, Quebec, Canada; University Hospital Jean-Minjoz (J.-P.B.), Besançon, France; Royal Infirmary of Edinburgh (K.A.A.F.), Edinburgh, UK; University of North Carolina (S.C.S.), Chapel Hill, NC; The Heart Research Institute (P.B.), Sydney, Australia; Centre for Molecular Epidemiology (C.-E.T.), National University of Singapore, Republic of Singapore; Antwerp University Hospital (L.V.G.), Antwerp, Belgium; Institut für Klinische Psychologie und Psychotherapie (H.-U.W.), Technische Universität Dresden, Dresden, Germany; Sanofi-Aventis (C.M.), Paris, France; and University of Texas Health Science Center (S.M.H.), San Antonio, Tex.
Correspondence to Dr Beverley Balkau, INSERM U780-IFR69, Research in Epidemiology and Biostatistics, 16 Ave Paul Vaillant-Couturier, 94807 Villejuif, France. E-mail balkau{at}vjf.inserm.fr
Received November 15, 2006; accepted May 29, 2007.
Background— Abdominal adiposity is a growing clinical and public health problem. It is not known whether it is similarly associated with cardiovascular disease (CVD) and diabetes mellitus in different regions around the world, and thus whether measurement of waist circumference (WC) in addition to body mass index (BMI) is useful in primary care practice.
Methods and Results— Randomly chosen primary care physicians in 63 countries recruited consecutive patients aged 18 to 80 years on 2 prespecified half days. WC and BMI were measured and the presence of CVD and diabetes mellitus recorded. Of the patients who consulted the primary care physicians, 97% agreed to participate in the present study. Overall, 24% of 69 409 men and 27% of 98 750 women were obese (BMI
30 kg/m2). A further 40% and 30% of men and women, respectively, were overweight (BMI 25 to 30 kg/m2). Increased WC (>102 for men and >88 cm for women) was recorded in 29% and 48%, CVD in 16% and 13%, and diabetes mellitus in 13% and 11% of men and women, respectively. A statistically significant graded increase existed in the frequency of CVD and diabetes mellitus with both BMI and WC, with a stronger relationship for WC than for BMI across regions for both genders. This relationship between WC, CVD, and particularly diabetes mellitus was seen even in lean patients (BMI<25 kg/m2).
Conclusions— Among men and women who consulted primary care physicians, BMI and particularly WC were both strongly linked to CVD and especially to diabetes mellitus. Strategies to address this global problem are required to prevent an epidemic of these major causes of morbidity and mortality.
This article has been cited by other articles:
![]() |
J. Axelsson The emerging biology of adipose tissue in chronic kidney disease: from fat to facts Nephrol. Dial. Transplant., July 16, 2008; (2008) gfn376v1. [Full Text] [PDF] |
||||
![]() |
S. E. Nissen, S. J. Nicholls, and K. Wolski Rimonabant and Progression of Atherosclerosis in Obese Persons--Reply JAMA, July 16, 2008; 300(3): 280 - 281. [Full Text] [PDF] |
||||
![]() |
P. Poirier Healthy Lifestyle: Even If You Are Doing Everything Right, Extra Weight Carries an Excess Risk of Acute Coronary Events Circulation, June 17, 2008; 117(24): 3057 - 3059. [Full Text] [PDF] |
||||
![]() |
J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Reaven Why a Cluster is Truly a Cluster: Insulin Resistance and Cardiovascular Disease Clin. Chem., May 1, 2008; 54(5): 785 - 787. [Full Text] [PDF] |
||||
![]() |
S. E. Nissen, S. J. Nicholls, K. Wolski, J. Rodes-Cabau, C. P. Cannon, J. E. Deanfield, J.-P. Despres, J. J. P. Kastelein, S. R. Steinhubl, S. Kapadia, et al. Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease: The STRADIVARIUS Randomized Controlled Trial JAMA, April 2, 2008; 299(13): 1547 - 1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sanz, P. R. Moreno, and V. Fuster The year in atherothrombosis. J. Am. Coll. Cardiol., March 4, 2008; 51(9): 944 - 955. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |